Shire (LON:SHP)‘s stock had its “sector performer” rating reaffirmed by stock analysts at RBC Capital in a report issued on Monday, Analyst RN reports.
Shares of Shire (LON:SHP) traded up 0.81% on Monday, hitting GBX 2731.00. 1,536,992 shares of the company’s stock traded hands. Shire has a one year low of GBX 1853.0001 and a one year high of GBX 2939.00. The stock has a 50-day moving average of GBX 2759. and a 200-day moving average of GBX 2421.. The company’s market cap is £14.977 billion.
A number of other analysts have also recently weighed in on SHP. Analysts at Societe Generale reiterated a “buy” rating on shares of Shire in a research note to investors on Friday. They now have a GBX 3,615 ($59.11) price target on the stock. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Shire in a research note to investors on Friday. They now have a GBX 3,200 ($52.32) price target on the stock. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Shire in a research note to investors on Wednesday, December 4th. They now have a GBX 3,850 ($62.95) price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of GBX 2,398.11 ($39.21).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.